Natural health product · NPN 80112620
MegaQuinone
Yes: licensed in Canada
The product licence is active. Whether the product is actually on the market is a separate, voluntary notice; the official record shows it.
Licence status Active; licensed September 3, 2021; licence last revised June 17, 2024.
- Natural Product Number (NPN)
- 80112620
- Licence holder
- Novozymes North America Inc.
- Dosage form
- Capsule
- Route
- Oral
- Licensing route
- Compendial
- First licensed
- September 3, 2021
- Licence last revised
- June 17, 2024
Also sold as
Other product names on the same licence.
- MegaQuinone K2-7
Medicinal ingredients
Per dosage unit, as licensed.
| Ingredient | Amount | Source and potency |
|---|---|---|
| Magnesium | 36 mg | Magnesium glycinate |
| Zinc | 15 mg | Zinc bisglycinate |
| Vitamin K1 | 46 mcg | Vitamin K1 |
| Vitamin K2 | 74 mcg | Menaquinone 7 |
What it is licensed for
The licence’s own wording. Directions, doses, cautions and warnings are on the official record and the label.
- Helps in connective tissue formation. Helps in energy metabolism and tissue formation. Helps in energy metabolism, tissue formation and bone development. Helps in the development and maintenance of bones and teeth and maintain proper muscle function and tissue formation. Helps in the maintenance of bones. Helps maintain healthy skin and connective tissue formation. Helps to maintain (proper) muscle function. Helps to maintain healthy bones, hair, nail and/or skin. Helps to maintain heart muscle function. Helps to maintain normal electrolyte balance. Helps with immune function. Provides/Source of/An electrolyte (for the maintenance of good health).
Non-medicinal ingredients
Cellulose; Hypromellose